
Cagrilintide + Semaglutide
This combination pairs Cagrilintide (an amylin analogue) with Semaglutide (a GLP-1 receptor agonist) to deliver dual-pathway metabolic support. Together, they target distinct satiety signals in the central nervous system and gut, resulting in enhanced appetite control and delayed gastric motility.
By addressing weight management from two complementary biological mechanisms, this blend offers a potent solution for aggressive body recomposition and metabolic optimization.
This product is intended for in-vitro laboratory research only. It is not a dietary supplement and is not for human consumption. By adding to cart you confirm the research-use disclaimer.




